There is a high demand for SARS-CoV-2 antiviral therapies that may limit COVID-19 severity in susceptible individuals. At the end of March, Health~Holland set up
‘De exacte inhoud houden we geheim’ Geschreven door: Robbert Roos Gaan we de strijd tegen het Corona-virus winnen met een dampvloeistof? Als het aan Martijn
Clinically-validated nasal airway epithelial cell models for COVID-19 high throughput drug development The current COVID-19 pandemic has a strong impact on individual health and social
Vossensteyn Biomedical is a young startup with a revolutionary outlook. We have a different view on the medical and microbiological world. Together with doctors, immunologists, microbiologists, pharmacists and microchemists we are developing new medications and treatments for infectious diseases